These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7140136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen.
    Reiter MJ, Shand DG, Aanonsen LM, Wagoner R, McCarthy E, Pritchett EL.
    Am J Cardiol; 1982 Oct; 50(4):716-21. PubMed ID: 7124631
    [Abstract] [Full Text] [Related]

  • 3. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG, Rocchini AP, Vasiliades J.
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism.
    Echizen H, Vogelgesang B, Eichelbaum M.
    Clin Pharmacol Ther; 1985 Jul; 38(1):71-6. PubMed ID: 4006378
    [Abstract] [Full Text] [Related]

  • 7. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L, Menichelli P, Alimenti M, Zuccala G, Gemma A, Cocchi A, Carbonin PU.
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [Abstract] [Full Text] [Related]

  • 8. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE, Keefe DL, Schwartz J, Harapat S, Kirsten EB, Harrison DC.
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
    McAllister RG, Bourne DW, Dittert LW.
    J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: investigations with a conventional and a controlled-release formulation.
    Harder S, Thürmann P, Siewert M, Blume H, Huber T, Rietbrock N.
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):207-12. PubMed ID: 1709224
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.
    John DN, Fort S, Lewis MJ, Luscombe DK.
    Br J Clin Pharmacol; 1992 Jun; 33(6):623-7. PubMed ID: 1389935
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Verapamil pharmacodynamics after intravenous and oral dosing: theoretic consideration.
    Colburn WA, Brazzell RK, Holazo AA.
    J Clin Pharmacol; 1986 Jan; 26(1):71-3. PubMed ID: 3950053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Age-related changes in the pharmacodynamics of verapamil.
    Arnold TH, Vallner JJ, Tackett RL.
    Am Heart J; 1985 Nov; 110(5):981-5. PubMed ID: 4061274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.